![](https://investorshub.advfn.com/uicon/478509.png?cb=1505989841)
Wednesday, October 07, 2020 1:06:45 PM
GENEVA and RADNOR, PA., May 14, 2020 – RELIEF THERAPEUTICS Holding AG (SIX:RLF) (Relief) and its U.S. partner, NeuroRx, Inc. announced today that NeuroRx has completed final manufacturing of investigational drug RLF-100 for Phase 2b/3 clinical trial to assess intravenous RLF-100 as a treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients on mechanical ventilation.
Bachem Americas (Torrance, Calif.) and MedisourceRx (Encinatas, Calif.) respectively manufactured RLF-100 drug substance and drug product under the supervision of NeuroRx scientists Richard Siegel, Ph.D., and Robert Besthof MIM who previously held leadership positions at Johnson & Johnson and Pfizer prior to joining NeuroRx. Manufacture and release of investigational product was completed within 60 days of FDA’s approval to proceed with the clinical trial.
MedisourceRx (Encinatas, Calif.)
https://www.medisourcerx.com/news
Bachem Americas (Torrance, Calif.)
https://www.bachem.com/news-media/press-releases/
https://relieftherapeutics.com/relief-therapeutics-and-neurorx-announce-final-manufacturing-validation-of-rlf-100-for-phase-2b3-clinical-trial-in-patients-with-covid-19-associated-acute-respiratory-distress-syndrome/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157470773
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM